Find your next paid study

Extensive-stage Small-cell Lung CancerLiver Metastases

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT06137144

Phase 2

IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free …

Osteogenesis Imperfecta (OI)

~$75 – $3,000

Actual pay is set by the research site.

Kamya SankarNCT05588388

Phase 2

A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.

Angitia Incorporated LimitedNCT07062588

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

Early Phase 1 Window of Opportunity Study of Oral DSP-0390 in Gliomas

This study focuses on determining the pharmacokinetic and pharmacodynamic effect of DSP-0390 in brain and blood from patients with IDH-mutant glioma undergoing…

Glioma, MalignantIDH Mutation

Washington University School of MedicineNCT06636162

~$150 – $3,000

Actual pay is set by the research site.

Investigating the Role of Potatoes in Boosting Vegetable Enjoyment and Consumption Among Adolescents and Emerging Adults

This study aims to examine how the amount of potato and form of potato within a meal impacts intake and acceptability of other non-starchy vegetables.

Dietary Exposure

~$10 – $1,125

Actual pay is set by the research site.

Sara MaksiNCT07202988

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patien…

Vestibular Schwannoma

Medical College of WisconsinNCT05702749

Actual pay is set by the research site.

Phase 4

AI-Powered Hepatitis C Single-Encounter Test-and-Treat

This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will rece…

HEPATITIS C (HCV)

~$25 – $1,500

Actual pay is set by the research site.

Patrick GraceNCT07793643

Malignant Brain TumorGliomaCoping Skills

NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors

This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed…

Massachusetts General HospitalNCT05976490

Actual pay is set by the research site.

Heart FailureMedication Optimization

Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver

Numerous pharmacotherapies have been proven to reduce mortality and hospitalization rates for heart failure with reduced ejection fraction (HFrEF) patients. Ho…

Denver Health and Hospital AuthorityNCT07435662

Actual pay is set by the research site.

Phase 2

Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia (The ALIGN-AML Trial)

This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and …

Acute Myeloid Leukemia

University of RochesterNCT07735208

~$75 – $2,000

Actual pay is set by the research site.

Developing At-home taVNS for Neurorehabilitation in Parkinson's Disease

The goal of this clinical trial is to learn if taVNS works to treat symptoms of Parkinson's Disease in adults. It will also learn about the feasibility and pre…

Parkinson's Disease

Medical University of South CarolinaNCT07536022

Actual pay is set by the research site.

Phase 3

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or g…

GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma